We are live on ! Find out more
TLIS

Talis Biomedical Corporation Common Stock
TLIS

Delisted

TLIS was delisted on the 30th of August, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of TLIS yet.

TLIS Hedge Fund Activity: Q1 2025 in Review

0 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Talis Biomedical Corporation Common Stock (TLIS) for Q1 2025, worth a combined $0 — down 100% from $26 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of TLIS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Synergy Asset Management, exiting entirely with an estimated $26 sold.

  • 0 institutional investors held Talis Biomedical Corporation Common Stock (TLIS) as of Q1 2025, down from 1 in Q4 2024.
  • Funds reported $0 of Talis Biomedical Corporation Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Talis Biomedical Corporation Common Stock positions in Q1 2025 and 1 closed out, a net change of -1 holder.
  • The largest Talis Biomedical Corporation Common Stock seller in Q1 2025 was Synergy Asset Management, an estimated $26 sold.

Based on aggregated 13F filings for Q1 2025.